Zinbryta (Daclizumab) for Multiple Sclerosis

Connect with others who understand.

Learn from expert-reviewed resources
Real advice from people who’ve been there
People who understand what you’re going through

On March 2, 2018, manufacturers Biogen and AbbVie announced that they were withdrawing Zinbryta (Daclizumab) from the market worldwide. The drug is no longer available.

For more details about this treatment, visit:
Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA (daclizumab) for Relapsing Multiple Sclerosis - Biogen
http://media.biogen.com/press-release/autoimmun...

MyMSTeam is the social network for those living with multiple sclerosis. Get the emotional support you need from others like you, and gain practical advice and insights on managing treatment or therapies for multiple sclerosis. MyMSTeam is the only social network where you can truly connect, make real friendships, and share daily ups and downs in a judgement-free place.

MyMSTeam is not a medical referral site and does not recommend or endorse any particular provider or medical treatment. No information on MyMSTeam should be construed as medical and/or health advice.

Connect with others who understand.

Zinbryta (Daclizumab) for Multiple Sclerosis

Get smarter about MS in less than 3 minutes for free.

Thank you for subscribing!